Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-04-14 @ 11:28 AM
Study NCT ID:
NCT01265927
Status:
COMPLETED
Last Update Posted:
2015-10-27
First Post:
2010-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
Sponsor:
Indiana University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IUCRO-0314
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None